North China Pharmaceutical Co Ltd (600812) — Capital Reinvestment Ratio
North China Pharmaceutical Co Ltd (600812) has a Capital Reinvestment Ratio of 0.85x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥170.24 Million) in capital expenditures (CN¥144.38 Million). Check North China Pharmaceutical Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
North China Pharmaceutical Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks North China Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see 600812 operating cash flow.
Annual Capital Reinvestment Ratio for North China Pharmaceutical Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for North China Pharmaceutical Co Ltd from 2000 to 2025. See North China Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.46x | CN¥1.18 Billion | CN¥542.01 Million | ▼ -27.8% |
| 2024 | 0.64x | CN¥1.23 Billion | CN¥784.22 Million | ▲ +4.9% |
| 2023 | 0.61x | CN¥1.02 Billion | CN¥623.04 Million | ▲ +11.2% |
| 2022 | 0.55x | CN¥1.00 Billion | CN¥549.58 Million | ▲ +5.0% |
| 2021 | 0.52x | CN¥1.05 Billion | CN¥547.50 Million | ▼ -61.1% |
| 2020 | 1.34x | CN¥752.15 Million | CN¥1.01 Billion | ▲ +51.9% |
| 2019 | 0.88x | CN¥732.97 Million | CN¥645.97 Million | ▲ +34.7% |
| 2018 | 0.65x | CN¥774.33 Million | CN¥506.64 Million | ▼ -53.0% |
| 2017 | 1.39x | CN¥287.25 Million | CN¥399.69 Million | ▼ -53.7% |
| 2015 | 3.00x | CN¥122.50 Million | CN¥367.81 Million | ▲ +5.3% |
| 2014 | 2.85x | CN¥90.56 Million | CN¥258.30 Million | ▼ -42.9% |
| 2011 | 4.99x | CN¥227.60 Million | CN¥1.14 Billion | ▲ +1279.5% |
| 2009 | 0.36x | CN¥1.01 Billion | CN¥366.10 Million | ▲ +184.8% |
| 2008 | 0.13x | CN¥1.09 Billion | CN¥138.00 Million | ▼ -14.1% |
| 2007 | 0.15x | CN¥664.37 Million | CN¥98.27 Million | ▲ +70.8% |
| 2006 | 0.09x | CN¥597.12 Million | CN¥51.72 Million | ▼ -89.5% |
| 2005 | 0.82x | CN¥224.17 Million | CN¥184.67 Million | ▼ -26.6% |
| 2004 | 1.12x | CN¥310.39 Million | CN¥348.50 Million | ▲ +47.2% |
| 2003 | 0.76x | CN¥580.32 Million | CN¥442.77 Million | ▲ +150.8% |
| 2002 | 0.30x | CN¥738.50 Million | CN¥224.68 Million | ▼ -41.7% |
| 2001 | 0.52x | CN¥367.28 Million | CN¥191.79 Million | ▼ -28.5% |
| 2000 | 0.73x | CN¥133.49 Million | CN¥97.52 Million | — |